Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net loss from continuing operations $ (5,752,003) $ (12,932,795)
Adjustments to reconcile net loss to net cash (used in) provided by operations:    
Depreciation and amortization 164,707 223,586
Stock-based compensation 8,650
Amortization of debt discount 18,433 3,458,021
Modification of warrants 4,056,424
Penalty for non-payment of debenture 595,440
Change in fair value of derivative instruments 105,076
Loss on sale of receivables to factor 305,400
Non-cash gain on assets (1,398)
Bargain purchase gain for Jellico Community Hospital and CarePlus Center (250,000)
Loss from discontinued operations (39,775) (508,609)
Changes in operating assets and liabilities:    
Accounts receivable 950,696 (1,059,478)
Inventory (36,420) 92,970
Prepaid expenses and other current assets (13,506) 59,074
Security deposits 50,000 69,784
Accounts payable and checks issued in excess of bank balance 569,245 3,013,045
Accrued expenses 2,708,902 1,723,743
Income tax assets and liabilities (1,118,485) (30,000)
Net cash used in operating activities of continuing operations (2,498,206) (1,071,067)
Net cash provided by operating activities of discontinued operations 26,943 185,942
Net cash used in operating activities (2,471,263) (885,125)
Cash flows from investing activities:    
Purchase of Jellico Community Hospital and CarePlus Center (658,537)
Purchase of property and equipment (42,317)
Net cash used in investing activities of continuing operations (700,854)
Net cash of investing activities of discontinued operations
Net cash used in investing activities (700,854)
Cash flows from financing activities:    
Proceeds from issuance of related party note payable and advances 3,094,953 1,373,788
Payments on related party note payable and advances (25,000) (660,000)
Proceeds from issuance of debentures 500,000
Payment of debentures (220,000)
Proceeds from issuance of note payable 1,077,116
Payments on notes payable (186,149) (5,513)
Proceeds from receivables sold to factor 570,000
Receivables paid to factor (1,073,854) (109,425)
Payments on right-of-use liabilities (50,194) (5,993)
Payments on capital lease obligations (100,707) (73,741)
Net cash provided by financing activities of continuing operations 2,516,165 1,589,116
Net cash financing activities of discontinued operations
Net cash provided by financing activities 2,516,165 1,589,116
Net increase in cash 44,902 3,137
Cash at beginning of period 16,933 6,870
Cash at end of period $ 61,835 $ 10,007